145 related articles for article (PubMed ID: 35491733)
1. Carboxyl Esterase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration-Resistant Prostate Cancer-Bearing Mice with Less Toxicity.
Kim JH; Oh E; Yun CW; Lee SH; Song YS
Technol Cancer Res Treat; 2022; 21():15330338221093146. PubMed ID: 35491733
[TBL] [Abstract][Full Text] [Related]
2. Carboxylesterase-overexpressing hTERT-immortalized human adipose stem cells in prostate tumor growth inhibition by irinotecan.
Kim JH; Oh E; Song ES; Yun CW; Lee SH; Song YS
J Cancer Res Ther; 2023 Oct; 19(7):1731-1742. PubMed ID: 38376272
[TBL] [Abstract][Full Text] [Related]
3. Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in castration-resistant prostate cancer.
Kim JH; Oh E; Han YS; Lee SH; Song YS
Prostate Int; 2021 Mar; 9(1):31-41. PubMed ID: 33912512
[TBL] [Abstract][Full Text] [Related]
4. Anti-Cancer Effect of Neural Stem Cells Transfected with Carboxylesterase and sTRAIL Genes in Animals with Brain Lesions of Lung Cancer.
Kim JH; Ahn JS; Lee DS; Hong SH; Lee HJ
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631070
[TBL] [Abstract][Full Text] [Related]
5. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer.
Kim JH; Yang HJ; Lee SH; Song YS
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791557
[TBL] [Abstract][Full Text] [Related]
6. Secreted TRAIL gene-modified adipose-derived stem cells exhibited potent tumor-suppressive effect in hepatocellular carcinoma cells.
Liu Z; Li S; Ma T; Zeng J; Zhou X; Li H; Tang M; Liu X; Li F; Jiang B; Zhao M; Chen Y
Immun Inflamm Dis; 2021 Mar; 9(1):144-156. PubMed ID: 33156578
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract][Full Text] [Related]
8. Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects.
Yu R; Deedigan L; Albarenque SM; Mohr A; Zwacka RM
Cell Death Dis; 2013 Feb; 4(2):e503. PubMed ID: 23429289
[TBL] [Abstract][Full Text] [Related]
9. Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.
Choi SA; Lee YE; Kwak PA; Lee JY; Kim SS; Lee SJ; Phi JH; Wang KC; Song J; Song SH; Joo KM; Kim SK
Cancer Gene Ther; 2015 Jun; 22(6):302-11. PubMed ID: 26021486
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific gene therapy for pancreatic cancer using human neural stem cells encoding carboxylesterase.
Choi SS; Yoon K; Choi SA; Yoon SB; Kim SU; Lee HJ
Oncotarget; 2016 Nov; 7(46):75319-75327. PubMed ID: 27659534
[TBL] [Abstract][Full Text] [Related]
11. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
[TBL] [Abstract][Full Text] [Related]
12. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
13. Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice.
Yi BR; Kim SU; Choi KC
Oncotarget; 2014 Dec; 5(24):12835-48. PubMed ID: 25544747
[TBL] [Abstract][Full Text] [Related]
14. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
[TBL] [Abstract][Full Text] [Related]
15. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma.
Choi SA; Yun JW; Joo KM; Lee JY; Kwak PA; Lee YE; You JR; Kwon E; Kim WH; Wang KC; Phi JH; Kang BC; Kim SK
Stem Cells Dev; 2016 Jun; 25(12):897-908. PubMed ID: 27151205
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
Choi SA; Lee C; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Chong S; Kim SK
Cancer Lett; 2019 Feb; 442():161-169. PubMed ID: 30367915
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer.
Seol HJ; Jin J; Seong DH; Joo KM; Kang W; Yang H; Kim J; Shin CS; Kim Y; Kim KH; Kong DS; Lee JI; Aboody KS; Lee HJ; Kim SU; Nam DH
Cancer Lett; 2011 Dec; 311(2):152-9. PubMed ID: 21868150
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases.
Hong SH; Lee HJ; An J; Lim I; Borlongan C; Aboody KS; Kim SU
Cancer Gene Ther; 2013 Dec; 20(12):678-82. PubMed ID: 24310061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]